Skip to content
PubMed This is a summary of 16 peer-reviewed journal articles Updated
Neurology

Monitoring, Anesthesia Risks, and Emergencies

At a Glance

Children with MICU1-related MPXPS need an individualized anesthesia and emergency plan: succinylcholine should be avoided, prolonged propofol infusions are generally avoided, and dark urine, sudden weakness, breathing trouble, or serious illness need urgent care.

Important Note: The information below is educational. Your treating team’s individualized emergency and anesthesia instructions always override general information in this guide.

While many children with MICU1-related MPXPS follow a relatively stable path, being prepared for emergencies and understanding the unique risks of anesthesia is a critical part of your role as a parent. Because your child’s mitochondria struggle to regulate calcium, their muscles are more vulnerable to certain triggers and stresses [1][2].

Navigating Anesthesia Safely

Surgery and anesthesia are significant “stress tests” for a child with a mitochondrial condition. There is no universal MICU1-specific protocol, so it is essential that you discuss your child’s diagnosis with an anesthesiologist experienced in neuromuscular or mitochondrial disease well in advance of any procedure to create an individualized plan.

  • Absolute Contraindications: Succinylcholine must be strictly avoided. In children with myopathies, this drug can cause a massive and life-threatening breakdown of muscle tissue (rhabdomyolysis), dangerous spikes in potassium, and cardiac arrest [3][4].
  • The Propofol Question: Propofol is commonly used for anesthesia, but in mitochondrial disease, prolonged use carries a risk of “propofol-infusion syndrome,” which can cause metabolic failure [3][5]. While a single brief dose may be tolerated depending on clinical context, prolonged infusions are generally avoided.
  • Individualized Approaches: Rather than a universal preferred method, anesthesiologists will choose techniques (which may include regional anesthesia when appropriate) based on your child’s specific needs. They should also aim to minimize the time your child spends fasting before surgery to prevent energy depletion [3][6].
  • Post-Operative Watch: After any procedure, your child needs close monitoring for respiratory compromise (difficulty breathing) and residual muscle weakness as they wake up [3][7].

Recognizing Emergency “Red Flags”

It is important to distinguish between daily fatigue—which is a normal part of living with MPXPS—and a true medical emergency. Daily tiredness or needing a nap after school are not emergencies. Do not attempt to manage severe symptoms by checking CK levels at home; rely on clinical signs.

Seek emergency medical care immediately if you notice:

  • Dark “Tea-Colored” Urine: This is a major warning sign of rhabdomyolysis (severe muscle breakdown). The dark color comes from muscle proteins like myoglobin, which can injure the kidneys [3][4].
  • Acute “Drop” in Strength: While some children have been reported to experience severe, sudden episodes of muscle weakness, a sudden inability to walk or move that is much worse than their “bad days” requires urgent evaluation [8].
  • Respiratory Distress: If your child has a very weak cough, is struggling to catch their breath, or seems unusually blue or pale around the lips [3][9].
  • Illness and Dehydration: Fever, vomiting, or reduced alertness. Follow a clinician-directed “sick-day plan” rather than waiting for a marked CK spike [8][10].

Long-Term Surveillance and Monitoring

Because MPXPS can affect several systems, your care team may set up a symptom-driven “surveillance” schedule based on general mitochondrial precautions to catch any changes early:

  1. Cardiac and Respiratory: While not universally established as a routine requirement, baseline and periodic ECGs and echocardiograms may be recommended as a general precaution to ensure the heart muscle remains strong. Similarly, pulmonary function tests may be used as your child gets older [11][12].
  2. Muscle and Mobility: Regular physical therapy assessments help track strength and coordinate any needed bracing or mobility aids. This also includes monitoring for hyperkyphosis (back curvature) or foot issues [13][14].
  3. Vision and Hearing: Periodic exams with an ophthalmologist to check for cataracts or drooping eyelids, and occasional hearing tests, may be recommended, as these issues are sometimes linked to mitochondrial conditions [10][15].
  4. Growth and Nutrition: Monitoring for poor growth or swallowing difficulties ensures your child is getting enough energy to support their already-stressed mitochondria [10][16].

Keeping a dedicated binder with your child’s most recent lab results, genetic reports, and an emergency protocol letter from your neurologist can save critical time during an ER visit or a pre-surgical consultation.

Common questions in this guide

Which anesthesia medicine must be avoided in MICU1-related MPXPS?
Succinylcholine should be strictly avoided in children with myopathies because it can cause rapid muscle breakdown, a dangerous rise in potassium, and cardiac arrest. The anesthesiologist should know about the MICU1-related MPXPS diagnosis before any procedure.
Can a child with MICU1-related MPXPS receive propofol?
A single brief dose may be tolerated in some situations, but prolonged propofol infusions are generally avoided in mitochondrial disease because they can cause propofol-infusion syndrome and metabolic failure. The anesthesiologist should decide whether and how to use it for the specific procedure.
What signs mean my child with MPXPS needs emergency care?
Seek immediate medical care for tea-colored urine, sudden severe weakness or inability to walk, trouble breathing, a weak cough, blue or pale lips, or reduced alertness. Fever, vomiting, diarrhea, or dehydration should be managed using the child's clinician-directed sick-day plan rather than waiting for a blood test to show a rise.
How can we tell normal fatigue from an emergency?
Daily tiredness or needing a nap after school can be part of living with MPXPS and is not automatically an emergency. A sudden drop in strength or inability to walk that is much worse than usual, especially with breathing symptoms or dark urine, needs urgent evaluation.
What monitoring might a child with MICU1-related MPXPS need?
Monitoring is individualized and may include heart tests such as an ECG or echocardiogram, breathing tests, physical therapy assessments, and checks of vision, hearing, growth, nutrition, and swallowing. The care team should decide which tests are needed and how often based on the child's symptoms.
What should we bring to the emergency department or before surgery?
Keep an emergency letter stating the MICU1-related MPXPS diagnosis and anesthesia precautions, along with recent laboratory results, genetic reports, and the child's usual strength and creatine kinase (CK) baseline. Sharing these records with emergency and anesthesia teams can help them compare changes and plan safely.

Get notified when new evidence is published on Proximal myopathy with extrapyramidal signs.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.

References

References (16)
  1. 1

    Molecular pathophysiology of human MICU1 deficiency.

    Kohlschmidt N, Elbracht M, Czech A, et al.

    Neuropathology and applied neurobiology 2021; (47(6)):840-855 doi:10.1111/nan.12694.

    PMID: 33428302
  2. 2

    Dysregulation of Mitochondrial Ca2+ Uptake and Sarcolemma Repair Underlie Muscle Weakness and Wasting in Patients and Mice Lacking MICU1.

    Debattisti V, Horn A, Singh R, et al.

    Cell reports 2019; (29(5)):1274-1286.e6 doi:10.1016/j.celrep.2019.09.063.

    PMID: 31665639
  3. 3

    Anaesthetic management of patients with myopathies.

    Schieren M, Defosse J, Böhmer A, et al.

    European journal of anaesthesiology 2017; (34(10)):641-649 doi:10.1097/EJA.0000000000000672.

    PMID: 28719515
  4. 4

    Anesthetic consideration for neuromuscular diseases.

    Katz JA, Murphy GS

    Current opinion in anaesthesiology 2017; (30(3)):435-440 doi:10.1097/ACO.0000000000000466.

    PMID: 28448298
  5. 5

    Anesthetic Management of a Patient With Mitochondrial Encephalomyopathy, Lactic Acidosis, and Stroke-Like Episodes Syndrome During Extensive Spinal Surgery With Both Motor Evoked Potentials and Somatosensory Evoked Potentials: A Case Report.

    Salehpoor MS, Paluska MR, Falcon R, et al.

    Cureus 2023; (15(10)):e47198 doi:10.7759/cureus.47198.

    PMID: 37854475
  6. 6

    Perioperative Management of an Adult Patient With Myoclonic Epilepsy With Ragged Red Fibers Syndrome: A Case Report.

    Valent A, Pharaboz A, Letord A, et al.

    A&A practice 2021; (15(2)):e01401 doi:10.1213/XAA.0000000000001401.

    PMID: 33577170
  7. 7

    Weaning difficulty after severe pneumonia in adult-onset mitochondrial myopathy with A3243G mutation in the mitochondrial tRNA gene: A case report.

    Peng X, Ma LX, Xiao C, et al.

    Heliyon 2023; (9(12)):e23300 doi:10.1016/j.heliyon.2023.e23300.

    PMID: 38149187
  8. 8

    Case report: Unusual episodic myopathy in a patient with novel homozygous deletion of first coding exon of MICU1 gene.

    Sharova M, Skoblov M, Dadali E, et al.

    Frontiers in neurology 2022; (13()):1008937 doi:10.3389/fneur.2022.1008937.

    PMID: 36425804
  9. 9

    Acute Respiratory Failure Is the Initial Manifestation in the Adult-Onset A3243G tRNALeu mtDNA Mutation: A Case Report and the Literature Review.

    Pan X, Wang L, Fei G, et al.

    Frontiers in neurology 2019; (10()):780 doi:10.3389/fneur.2019.00780.

    PMID: 31379729
  10. 10

    A Middle Eastern Founder Mutation Expands the Genotypic and Phenotypic Spectrum of Mitochondrial MICU1 Deficiency: A Report of 13 Patients.

    Musa S, Eyaid W, Kamer K, et al.

    JIMD reports 2019; (43()):79-83 doi:10.1007/8904_2018_107.

    PMID: 29721912
  11. 11

    Screening and prevalence of cardiac abnormalities on electro- and echocardiography in a large cohort of patients with mitochondrial disease.

    Hendrix CLF, van den Heuvel FMA, Rodwell L, et al.

    Molecular genetics and metabolism 2022; (136(3)):219-225 doi:10.1016/j.ymgme.2022.05.004.

    PMID: 35659503
  12. 12

    Primary mitochondrial disease as a rare cause of unclear breathlessness and distinctive performance degradation - a case report.

    Ewert R, Elhadad MA, Habedank D, et al.

    BMC pulmonary medicine 2023; (23(1)):104 doi:10.1186/s12890-023-02391-x.

    PMID: 36991405
  13. 13

    Development of a Mitochondrial Myopathy-Composite Assessment Tool.

    Flickinger J, Fan J, Wellik A, et al.

    JCSM clinical reports 2021; (6(4)):109-127.

    PMID: 35071983
  14. 14

    Compound heterozygous mutations in MICU1 cause myopathy with extrapyramidal signs in two Chinese pedigrees.

    Li J, Liu H, Gan X, et al.

    Frontiers in neurology 2025; (16()):1624830 doi:10.3389/fneur.2025.1624830.

    PMID: 41018190
  15. 15

    Pathogenic mtDNA variants, in particular single large-scale mtDNA deletions, are strongly associated with post-lingual onset sensorineural hearing loss in primary mitochondrial disease.

    Elander J, McCormick EM, Värendh M, et al.

    Molecular genetics and metabolism 2022; (137(3)):230-238 doi:10.1016/j.ymgme.2022.09.002.

    PMID: 36182714
  16. 16

    Mitochondrial encephalopathies and myopathies: Our tertiary center's experience.

    Ozlu C, Messahel S, Minassian B, Kayani S

    European journal of paediatric neurology : EJPN : official journal of the European Paediatric Neurology Society 2024; (50()):31-40 doi:10.1016/j.ejpn.2024.03.005.

    PMID: 38583367

This page is for informational purposes only and does not constitute medical advice. Anesthesia and emergency plans for a child with MICU1-related MPXPS must be individualized with the child's treating team.